Evidence map›Paper›PMID 21486776›Full record

ArticleThe Journal of physiology2011

Adenosine A2A receptor induces protein kinase A-dependent functional modulation of human (alpha)3(beta)4 nicotinic receptor.

Silvia Di Angelantonio, Alessio Piccioni, Claudia Moriconi, Flavia Trettel, Gloria Cristalli, Francesca Grassi, Cristina Limatola

Open access · greenAbstract read
In one paragraph

Article in The Journal of physiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Ethanol-Induced Motor Impairment Mediated by Inhibition of α7 Nicotinic Receptors.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2016
    Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Silvia Di AngelantonioDipartimento di Fisiologia e Farmacologia, Università Sapienza, P.le A. Moro 5; I-00185 Roma, Italy.
Alessio Piccioni
Claudia Moriconi
Flavia Trettel
Gloria Cristalli
Francesca Grassi
Cristina Limatola
Istituto Pasteur · ITSapienza University of Rome · ITUniversità di Camerino · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adenosine modulates the function of nicotinic ACh receptors (nAChRs) in a variety of preparations, possibly through pathways involving protein kinase A (PKA), but these phenomena have not yet been investigated in detail. In this work we studied, using the patch clamp technique, the functional modulation of recombinant human α3β4 nAChR by the A2A adenosine receptor, co-expressed in HEK cells. Tonic activation of A2A receptor slowed current decay during prolonged applications of nicotine and accelerated receptor recovery from desensitization. Together, these changes resulted into a more sustained current response upon multiple nicotine or ACh applications. These findings were confirmed in cultured mouse superior cervical ganglion neurones, which express nAChR containing the α3 subunit together with β2 and/or β4 and A2A receptor. Expression of the A2A receptor in HEK cells also increased the apparent potency of nAChR for nicotine, further supporting a general A2A-induced gain of function for nAChR. These effects were dependent on PKA since the direct activation of PKA mimicked, and its inhibition prevented almost completely, the effects of the A2A receptor. Mutations of R385 and S388 in the cytoplasmic loop of the α3 subunit abolished the functional modulation of nAChR induced by activation of A2A receptor, PKA and other Ser/Thr kinases, suggesting that this region constitutes a putative consensus site for these kinases. These data provide conclusive evidence that activation of the A2A receptor determines functional changes

Indexed as

2-Chloroadenosine8-Bromo Cyclic Adenosine MonophosphateAcetylcholineAdenosine A2 Receptor AgonistsAdenosine A2 Receptor AntagonistsAdenosine DeaminaseAmino Acid SubstitutionAmyotrophic Lateral SclerosisAnimalsAnimals, NewbornCarbazolesCells, CulturedCyclic AMP-Dependent Protein Kinase Catalytic SubunitsCyclic AMP-Dependent Protein KinasesDose-Response Relationship, DrugElectrophysiological Phenomena2-Chloroadenosine5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidine8-Bromo Cyclic Adenosine MonophosphateAcetylcholineAdenosine A2 Receptor AgonistsAdenosine A2 Receptor AntagonistsAdenosine DeaminaseCarbazolesCyclic AMP-Dependent Protein Kinase Catalytic SubunitsCyclic AMP-Dependent Protein KinasesKT 5720Nicotinenicotinic receptor alpha3beta4Protein Kinase InhibitorsProtein Serine-Threonine KinasesPyrimidinesPyrrolesReceptor, Adenosine A2AReceptors, NicotinicTriazoles

Identifiers

PMID21486776
PMCPMC3112553
OpenAlexW1551448995

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.